Gliknik Inc.

3 clinical trials · Sponsor

Record	Firm	Date
Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia (NCT07605845)	Gliknik Inc.	2026-04-14
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease (NCT05318534)	Gliknik Inc.	2022-04-08
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity (NCT02873819)	Gliknik Inc.	2017-03-30

Every clearance here is in the API, with alerts when new ones post.